Centre Hospitalier De Niort

At Centre Hospitalier De Niort, research in neoplasms and blood cancers focuses on improving treatment outcomes for patients with cancers of the sinuses, salivary glands, colon, anal region, and lymphatic system, as well as multiple myeloma and follicular lymphoma. These studies are designed to compare treatment approaches, strengthen disease control, and improve survival.

• Resected and non-operable tumors of the sinuses or salivary glands
• Locally advanced anal squamous cell carcinoma
• High-risk stage III colon cancer and colorectal adenomas
• Untreated follicular lymphoma and multiple myeloma

Overall, the site is contributing to trials that test new cancer therapies and evaluate whether alternative treatment strategies can improve long-term disease-free and progression-free outcomes.

This research area covers a broad range of immune system diseases, including rheumatoid arthritis, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, IgA vasculitis, pemphigus, and mucous membrane pemphigoid. The studies aim to refine remission strategies, reduce relapses, and improve symptom control for people living with chronic autoimmune conditions.

• Rheumatoid arthritis and treatment-resistant disease
• ANCA-associated vasculitis, including GPA and MPA
• EGPA and IgA vasculitis
• Pemphigus diseases and severe mucous membrane pemphigoid

Much of the work at this hospital site in Niort explores whether targeted therapies can offer better remission maintenance and lower the need for long-term steroid use.

Studies in cardiovascular diseases at this centre include acute myocardial infarction and prevention of clot-related complications in patients with lower limb trauma. The research is aimed at improving pain relief, early emergency care, and prevention of serious thromboembolic events.

• Acute myocardial infarction and prehospital pain management
• High-risk lower limb trauma requiring immobilisation
• Prevention of symptomatic thromboembolic events

These trials support practical clinical questions, such as whether a treatment can provide effective relief with better tolerance or offer safer prevention strategies in urgent care settings.

Within digestive system diseases, the site is involved in research on colorectal cancer risk and prevention, especially in people with Lynch syndrome. The studies look at whether preventive treatment can reduce the appearance of new or recurrent colorectal adenomas and help lower cancer risk over time.

• Lynch syndrome and colorectal adenomas
• High-risk colon cancer
• Adjuvant treatment strategies in colorectal disease

This area reflects a strong interest in early intervention and cancer prevention, with a focus on improving long-term outcomes in patients with inherited risk.

Research also extends to skin and connective tissue diseases and related inflammatory lung disease, including systemic sclerosis-associated interstitial lung disease. These trials evaluate maintenance approaches that may help preserve remission and support stable disease control after initial treatment.

• Systemic sclerosis-associated interstitial lung disease
• Maintenance treatment after remission induction
• Autoimmune skin blistering disorders

By examining whether ongoing therapy can sustain benefit, the site is helping advance care for patients with chronic, difficult-to-manage immune-mediated conditions.